
Keywords: BBB; blood brain barrier; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; H215O; 15O-water; FDG; 18F-fluorodeoxyglucose; CBF; cerebral blood flow; CMR; cerebral metabolic rate for glucose; GP; globus pallidus; LID; levodopa-induced dyskinesia; VOI; vo